Search

for
Search:

Community Join

5 / 1000+ results

community Low topical fin + 0.5% pyrilutamide

2 upvotes 6 months ago

Using a combination of low-dose topical finasteride (0.025%) and 0.5% pyrilutamide for hair loss, with a focus on minimizing side effects. The user seeks experiences and results from others who have tried this combination.

community What Do You Guys Think of This Article That Claims Low Dosage Topical Finastride Has No Effect on Serum DHT

in Research/Science 12 upvotes 1 year ago

Low-dose topical finasteride may reduce scalp DHT with fewer side effects than oral finasteride, though it can still lower blood serum DHT. Users report varying experiences, with some finding topical use effective and side-effect-free, while others note significant DHT suppression.

community Conceived on low dose topical fin (.025%), anyone else?

8 upvotes 6 months ago

A user expressed concern about using low-dose topical finasteride while conceiving, but was reassured that the risk of affecting a fetus is negligible. The user stopped using finasteride during pregnancy and switched to minoxidil and ketoconazole, while others shared experiences and advice on using these treatments safely.

community Success with low dose topicals?

8 upvotes 4 weeks ago

The conversation discusses switching from oral dutasteride to low-dose topical treatments due to side effects, with users sharing experiences using topical finasteride and dutasteride. The focus is on balancing hair regrowth with minimizing side effects like reduced libido and mood changes.

community Progress with low-dose topicals

in Research/Science 4 upvotes 5 months ago

The conversation discusses using low-dose topical finasteride, specifically 0.005% and 0.01%, for hair regrowth, with some users considering increasing the concentration for better results. Users share experiences with different dosages and combinations, including minoxidil, and discuss the effectiveness and availability of these treatments.

View more "low-toxic" in community →

Research

5 / 1000+ results

research Low-dose daily aspirin reduces topical minoxidil efficacy in androgenetic alopecia patients

12 citations , September 2018 in “Dermatologic Therapy”

This study found that 14 days of low-dose aspirin reduced the predicted response to topical minoxidil in androgenetic alopecia patients from 50% to 27%, suggesting aspirin may inhibit minoxidil efficacy.

research A systematic review on the treatment of pediatric severe alopecia areata by topical immunotherapy or Anthralin (contact sensitization) or low‐level light/laser therapy (LLLT): focus on efficacy, safety, treatment duration, recurrence, and follow‐up based on clinical studies

17 citations , October 2021 in “Journal of Cosmetic Dermatology”

This review found that topical immunotherapy and light/laser therapy may achieve over 50% hair regrowth efficacy in treating extensive alopecia areata in children, with no serious side effects observed.

Low-Dose Oral Minoxidil And Topical Minoxidil: Consensus Recommendations For Managing Male And Female Pattern Hair Loss In Hair Transplant Patients Using A Modified Delphi Process

research Low-dose oral minoxidil (LDOM) and topical minoxidil: consensus recommendations for managing male and female pattern Hair loss in Hair transplant patients using a modified delphi process

March 2026 in “Figshare”

This study developed consensus guidelines for the use of low-dose oral and topical minoxidil in male and female pattern hair loss, recommending specific doses, monitoring procedures, and timing of application around hair transplant surgeries.

research Low-dose oral minoxidil (LDOM) and topical minoxidil: consensus recommendations for managing male and female pattern Hair loss in Hair transplant patients using a modified delphi process

March 2026 in “Figshare”

This study developed expert consensus guidelines on using low-dose oral and topical minoxidil for pattern hair loss around hair transplant surgery, recommending specific doses, monitoring practices, and timing of use for both male and female patients.

research Low-dose oral minoxidil (LDOM) and topical minoxidil: consensus recommendations for managing male and female pattern hair loss in hair transplant patients using a modified Delphi process

March 2026 in “Figshare”

This study developed consensus guidelines for using low-dose oral and topical minoxidil in patients undergoing hair transplant surgery for pattern hair loss, recommending dosing adjustments, monitoring protocols, and timing for post-surgery application.

View more "low-toxic" in research →

Learn

10 / 801 results

learn Low Level Laser Therapy

Can low level laser therapy be combined with topical treatments like minoxidil? Yes, low level laser therapy can be safely combined with minoxidil.

learn sh-Polypeptide-7

Are there any safety concerns or allergic reactions associated with sh-Polypeptide-7 in topical hair products? There are no published human studies on sh-Polypeptide-7 itself, so its safety is unestablished; research on cosmetic peptides as a class reports low irritation and rare allergy, and dermatologists advise patch testing a new scalp product.

learn Hydrocortisone

When should hydrocortisone be used for hair loss — is it only for irritated scalps or also alopecia areata? Hydrocortisone is a low-potency topical steroid whose labelled use is calming scalp irritation such as dermatitis; for alopecia areata no verified human trial supports it on its own, and dermatologists generally use stronger prescription corticosteroids instead.

learn Botox

What’s the science behind Botox injections for androgenetic alopecia? Small published studies and a 2025 meta-analysis report hair-count gains from scalp botulinum toxin injections, but nearly all of them lack control groups, and reviewers of the same literature call the evidence low-quality; the treatment is off-label and not approved for hair loss anywhere.

learn Minoxidil

From hypertension to hair: the unexpected story of minoxidil Minoxidil was developed as an oral blood-pressure drug and approved as Loniten in 1979; unwanted hair growth in patients led to topical Rogaine, approved for men in 1988 and for women in 1991. Trials support topical minoxidil for pattern hair loss, while low-dose oral minoxidil is a prescription drug used off-label and needs medical supervision.

learn Stemoxydine

chemical from L'Oreal that encourages hair to enter growth phase

learn Neem Oil

natural substance from Neem tree with medicinal and pesticidal properties

learn Overview

learn Osteopontin

signaling protein that, when suppressed, may grow hair by reducing inflammation and stem cell loss

learn Thymosin Beta 4

View more "low-toxic" in learn →

Clinics

3 / 3 results

Experts

— no results

Try a deeper search in experts →